Importantly, whilst there was no significant difference between groups in diabetes duration at screening, graphs showed that seven participants in liraglutide arm had duration 5 years, but only four participants in placebo had duration 5 years
Sitagliptin and Metformin Co-administration in Patients with Type 2 Diabetes Inadequately Controlled on Diet and Exercise Table 1 summarizes the most common (5% of patients) adverse reactions reported (regardless of investigator assessment of causality) in a 24-week placebo-controlled factorial study in which sitagliptin and metformin were co-administered to patients with type 2 diabetes inadequately controlled on diet and exercise
Nutrition anchors: Protein, fiber, hydration, and steady meals help the medication work better and make weight loss feel easier
Quick disclosure: this is an affiliate link
Patients prescribed GLP-1 therapies often differ in baseline characteristics from those receiving alternative medications
Mineral Salt : Not all salts are created equal
